|

Multimodal Clinical Study of Electroconvulsive Therapy and Magnetic Seizure Therapy

RECRUITINGN/ASponsored by The Second Hospital of Anhui Medical University
Actively Recruiting
PhaseN/A
SponsorThe Second Hospital of Anhui Medical University
Started2025-09-01
Est. completion2027-12
Eligibility
Age12 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07473648

Summary

To compare the efficacy and tolerability of Electroconvulsive Therapy (ECT) and Magnetic Seizure Therapy (MST) in patients with major depressive disorder (MDD).

Eligibility

Age: 12 Years – 80 YearsHealthy volunteers accepted
Patients Inclusion Criteria:

Aged 12-80 years; Diagnosis confirmed by two psychiatrists per DSM-5; Stable medication regimen pre-enrollment; Indicated for neuromodulation OR with visual field defects.

Patients Exclusion Criteria:

Major systemic diseases; Prior neuromodulation within 3 months; Pregnancy or potential pregnancy; Metal implants or claustrophobia.

Healthy Control Inclusion Criteria:

Aged 12-80 years; No history of neuropsychiatric disorders; No significant systemic diseases; Normal or corrected vision.

Healthy Control Exclusion Criteria:

Metal implants or claustrophobia; Ocular diseases or surgery history.

Conditions4

DepressionElectroconvulsive TherapyMagnetic Seizure TherapyMajor Depressive Disorder

Browse More Trials

Depression trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.